Literature DB >> 17243007

Immunomodulation of the anti-islet CD8 T cell response by B7-2.

Deepak Yadav1, Nora Sarvetnick.   

Abstract

The absence of diabetes in NOD mice devoid of B7-2 signifies a critical role played by B7-2 in promoting autoimmunity. We asked whether the CD8 T cell compartment is impacted by the absence of B7-2. We found significantly lower expansion of anti-islet CD8 T cells in B7-2KO mice, although their survival and activation states remained unchanged in the pancreatic lymph nodes (PLNs). CD8 T cells from B7-2KO mice exhibited significantly diminished effector function compared to NOD mice. Adoptive transfer experiments using in vitro activated anti-islet CD8 T cells showed that B7-2 does not control the effector phase of the autoreactive CD8 T cell response. Our data indicate that B7-2 promotes pancreatic autoimmunity by controlling CD8 T cell expansion and effector function, but is dispensable for CD8 T cell activation, survival, and the effector phase of anti-islet CD8 T cell response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17243007     DOI: 10.1007/s10875-006-9067-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

1.  Cutting edge: naive T cells masquerading as memory cells.

Authors:  K Murali-Krishna; R Ahmed
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

2.  Immunology. CD8 T cells remember with a little help.

Authors:  Susan M Kaech; Rafi Ahmed
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 3.  Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.

Authors:  J W Yoon; H S Jun; P Santamaria
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

4.  Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.

Authors:  A N Schweitzer; F Borriello; R C Wong; A K Abbas; A H Sharpe
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

Review 5.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Authors:  B Salomon; J A Bluestone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.

Authors:  P E Fields; R J Finch; G S Gray; R Zollner; J L Thomas; K Sturmhoefel; K Lee; S Wolf; T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

7.  B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

Authors:  Deepak Yadav; Valeria Judkowski; Malin Flodstrom-Tullberg; Lori Sterling; William L Redmond; Linda Sherman; Nora Sarvetnick
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.

Authors:  B Salomon; L Rhee; H Bour-Jordan; H Hsin; A Montag; B Soliven; J Arcella; A M Girvin; J Padilla; S D Miller; J A Bluestone
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.